Literature DB >> 7283508

Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor.

S R Friesen, T Tomita.   

Abstract

The purpose of the investigation was to detect ulcer patients having nontumorous hypergastrinemic hyperchlorhydria and to diagnostically differentiate this pseudo-Zollinger-Ellison syndrome from neurogenic duodenal ulcer disease and pancreatic gastrinomas. Nine patients having clinical, radiologic and humoral findings simulating the Zollinger-Ellison syndrome or severe duodenal ulcer disease were studied by physiologic provocative testing. The patients, not having pancreaticoduodenal gastrinomas, had an antral mucosal source of their moderate hypergastrinemia even after vagotomy with drainage, which was eliminated in eight patients treated by surgical antrectomy, resulting in normal serum gastrin concentrations. The pseudo-Zollinger-Ellison syndrome is, thus, characterized physiologically by an exaggerated gastrin response to meals, no response to secretin stimulation and pathologically by hyperfunctioning hyperplastic G cells of the antrum. The clinical, physiologic, pathologic and surgical features were integrated for accurate diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283508      PMCID: PMC1345327          DOI: 10.1097/00000658-198110000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  38 in total

1.  Ectopic apudocarcinomas and associated endocrine hyperplasias of the foregut.

Authors:  S R Friesen; J E McGuigan
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

2.  Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome.

Authors:  S Ingemansson; L I Larsson; A Lunderquist; F Stadil
Journal:  Am J Surg       Date:  1977-11       Impact factor: 2.565

Review 3.  Radioimmunoassay in gastroenterology.

Authors:  S A Berson; R S Yalow
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

4.  Calcium challenge in the Zollinger-Ellison syndrome.

Authors:  E Passaro; N Basso; J H Walsh
Journal:  Surgery       Date:  1972-07       Impact factor: 3.982

5.  Preoperative angiography in the Zollinger-Ellison syndrome.

Authors:  P Giacobazzi; E Passaro
Journal:  Am J Surg       Date:  1973-07       Impact factor: 2.565

6.  Hypersecretion of gastrin associated with the short bowel syndrome.

Authors:  E Straus; C D Gerson; R S Yalow
Journal:  Gastroenterology       Date:  1974-02       Impact factor: 22.682

7.  D cell pathology in duodenal ulcers and achlorhydria.

Authors:  J M Polak; S R Bloom; A E Bishop; M V McCrossan
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

8.  Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas.

Authors:  J M Polak; S R Bloom; T E Adrian; P Heitz; M G Bryant; A G Pearse
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

9.  Gastric gastrinoma and diffuse G cell hyperplasia associated with chronic atrophic gastritis. Endoscopic detection and removal.

Authors:  A Russo; R Buffa; G Grasso; G Giannone; G Sanfilippo; F Sessa; E Solcia
Journal:  Digestion       Date:  1980       Impact factor: 3.216

10.  Several standard elective operations for duodenal ulcer: ten to 16 year clinical results.

Authors:  J C Goligher; D B Feather; R Hall; R A Hall; D Hopton; T E Kenny; A J Latchmore; T Matheson; J H Shoesmith; F G Smiddy; J Willson-Pepper
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

View more
  8 in total

Review 1.  Hyperplastic proliferations of enteroendocrine cells.

Authors:  Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  1994-03       Impact factor: 3.943

2.  Further experience with Pseudo-Zollinger-Ellison syndrome: its place in the management of neuroendocrine duodenal ulceration.

Authors:  S R Friesen; T Tomita
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

3.  Development of an inveterate gastroduodenal ulcer caused by antral G-cell hyperplasia of the stomach (pseudo-Zollinger-Ellison Syndrome): report of a case.

Authors:  S Takeno; T Noguchi; N Kubo; T Sato; Y Uchida; A Moriuchi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

4.  Conditional deletion of menin results in antral G cell hyperplasia and hypergastrinemia.

Authors:  Natalia A Veniaminova; Michael M Hayes; Jessica M Varney; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-05       Impact factor: 4.052

Review 5.  Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.

Authors:  Martin Anlauf; Nele Garbrecht; Tobias Henopp; Anja Schmitt; Regina Schlenger; Andreas Raffel; Markus Krausch; Oliver Gimm; Claus F Eisenberger; Wolfram T Knoefel; Henning Dralle; Paul Komminoth; Philipp U Heitz; Aurel Perren; Gunter Klöppel
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 6.  Current diagnosis and management of Zollinger-Ellison syndrome.

Authors:  D K Andersen
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

Review 7.  Hypergastrinemia.

Authors:  Sunil Dacha; Mohammed Razvi; Julia Massaad; Qiang Cai; Mohammad Wehbi
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02-18

Review 8.  Gastrinoma--morphological aspects.

Authors:  Günter Klöppel; Martin Anlauf
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 2.275

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.